Vasodilators: Peripheral
PDL Status Values
Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the
Non-Preferred Drugs in Select PDL Classes prior authorization criteria.
New drugs will be listed as N until reviewed by the P&T Committee and are subject to the
New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.
To request a Prior Authorization, please use this form.
| NDC | Brand Name | Generic Name | Form | Strength | PDL Status |
Rebate | Current Drug Use Criteria |
|---|---|---|---|---|---|---|---|
| 53489028101 | ERGOLOID MESYLATES | ergoloid mesylates | TABLET | 1 mg | Y | ||
| 00517400201 | PAPAVERINE HCL | papaverine HCl | VIAL | 30 mg/mL | Y | ||
| 00517400225 | PAPAVERINE HCL | papaverine HCl | VIAL | 30 mg/mL | Y | ||
| 14789012105 | PAPAVERINE HCL | papaverine HCl | VIAL | 30 mg/mL | Y | ||
| 14789012107 | PAPAVERINE HCL | papaverine HCl | VIAL | 30 mg/mL | Y | ||
| 72516002401 | PAPAVERINE HCL | papaverine HCl | VIAL | 30 mg/mL | Y | ||
| 72516002410 | PAPAVERINE HCL | papaverine HCl | VIAL | 30 mg/mL | Y | ||
| 72516002425 | PAPAVERINE HCL | papaverine HCl | VIAL | 30 mg/mL | Y |